Literature DB >> 24292193

[HIV prophylaxis kits. A concept for emergency treatment in the context of postexposure prophylaxis].

S Wicker1, F Walcher, S Wutzler, I Marzi, C Stephan.   

Abstract

Occupational transmission of HIV among healthcare personnel is rare but has repeatedly been published in the literature. Early initiation of postexposure HIV prophylaxis (HIV-PEP) is crucial to prevent virus transmission. For this reason the need for HIV-PEP has to be evaluated immediately and if necessary, started as soon as possible. This article presents an early intervention program in a university hospital which enables healthcare personnel immediate 24/7/365 access to a HIV-PEP prophylaxis kit following occupational HIV exposure.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24292193     DOI: 10.1007/s00104-013-2641-6

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  9 in total

Review 1.  Clinical practice. Occupational exposure to HIV in health care settings.

Authors:  Julie Louise Gerberding
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

Review 2.  [Comorbidity: anemia and heart failure].

Authors:  F Mahfoud; I Kindermann; M Kindermann; C Ukena; M Böhm
Journal:  Dtsch Med Wochenschr       Date:  2009-04-07       Impact factor: 0.628

3.  Failure of HIV postexposure prophylaxis after a work-related needlestick injury.

Authors:  Adrian Camacho-Ortiz
Journal:  Infect Control Hosp Epidemiol       Date:  2012-06       Impact factor: 3.254

4.  Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury.

Authors:  R Ridzon; K Gallagher; C Ciesielski; M B Ginsberg; B J Robertson; C C Luo; A DeMaria
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

5.  The management of needlestick injuries.

Authors:  Heiko Himmelreich; Holger F Rabenau; Matthias Rindermann; Christoph Stephan; Markus Bickel; Ingo Marzi; Sabine Wicker
Journal:  Dtsch Arztebl Int       Date:  2013-02-01       Impact factor: 5.594

6.  [Early diagnosis of hepatitis C transmission after needlestick injury].

Authors:  H Himmelreich; C M Sarrazin; C Stephan; H F Rabenau; I Marzi; S Wicker
Journal:  Unfallchirurg       Date:  2013-07       Impact factor: 1.000

7.  Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker.

Authors:  Elise M Beltrami; Anne Kozak; Ian T Williams; Ae M Saekhou; Marcia L Kalish; Omana V Nainan; Susan L Stramer; Mei-Chen H Fucci; Debra Frederickson; Denise M Cardo
Journal:  Am J Infect Control       Date:  2003-05       Impact factor: 2.918

8.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

9.  Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen.

Authors:  Elise M Beltrami; Chi-Cheng Luo; Nicolas de la Torre; Denise M Cardo
Journal:  Infect Control Hosp Epidemiol       Date:  2002-06       Impact factor: 3.254

  9 in total
  3 in total

1.  [High-risk needlestick injuries and virus transmission : A prospective observational study].

Authors:  N Safari; H F Rabenau; C Stephan; S Wutzler; I Marzi; S Wicker
Journal:  Unfallchirurg       Date:  2020-01       Impact factor: 1.000

2.  Best practice for needlestick injuries.

Authors:  S Wicker; F Walcher; S Wutzler; C Stephan; I Marzi
Journal:  Eur J Trauma Emerg Surg       Date:  2014-01-31       Impact factor: 3.693

3.  [Prevalence of blood-borne pathogens among 275 trauma patients : A prospective observational study].

Authors:  S Wicker; H F Rabenau; B Scheller; I Marzi; S Wutzler
Journal:  Unfallchirurg       Date:  2016-08       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.